Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum cholesterol reduction with tamoxifen.

D V Schapira1, N B Kumar, G H Lyman

  • 1Section of Cancer Prevention, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612.

Breast Cancer Research and Treatment
|November 1, 1990
PubMed
Summary

Tamoxifen significantly lowers serum cholesterol in women with early-stage breast cancer. This reduction in cholesterol may offer an added benefit of decreased cardiovascular risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Case of Myelitis Ending in Recovery.

Buffalo medical and surgical journal·2023
Same author

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Supportive care in patients with cancer during the COVID-19 pandemic.

ESMO open·2021
Same author

Personalized cancer supportive care in COVID-19 era.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Overall survival and risk of second malignancies with cancer chemotherapy and G-CSF support.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Impact of Dietary Factors and Inflammation on Cognition among Older Adults.

The journal of prevention of Alzheimer's disease·2017

Area of Science:

  • Oncology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Tamoxifen is a widely used endocrine therapy for breast cancer.
  • Elevated cholesterol is a risk factor for cardiovascular disease.
  • The impact of tamoxifen on serum cholesterol levels in breast cancer patients requires further elucidation.

Purpose of the Study:

  • To compare serum cholesterol levels in women with early-stage breast cancer receiving tamoxifen versus a control group.
  • To identify factors influencing changes in serum cholesterol during tamoxifen treatment.

Main Methods:

  • A comparative study involving 123 women with Stage I/II breast cancer on tamoxifen and 81 controls not on hormonal therapy.
  • Serum cholesterol levels were measured and compared between groups.
  • Multivariate analysis was used to assess the impact of tamoxifen, initial cholesterol, and age on cholesterol reduction.

Main Results:

  • Tamoxifen administration led to a significantly greater mean decrease in serum cholesterol (34.2 mg/dl) compared to controls (1.0 mg/dl) (P < 0.001).
  • A substantial percentage of women on tamoxifen experienced significant cholesterol reduction (>10 mg/dl: 72.9% vs. 35.1%; >40 mg/dl: 39.9% vs. 12.6%).
  • Tamoxifen use, baseline cholesterol, and age were significant predictors of cholesterol decrease.

Conclusions:

  • Adjuvant tamoxifen therapy significantly reduces serum cholesterol levels in women with newly diagnosed breast cancer.
  • The cholesterol-lowering effect of tamoxifen may contribute to a reduced cardiovascular risk profile in these patients.
  • Further research is warranted to confirm the long-term cardiovascular benefits of tamoxifen-induced hypercholesterolemia reduction.

Related Experiment Videos